암닐 파마슈티컬스(AMRX)는 NASDAQ에 상장된 Healthcare · Drug Manufacturers - Specialty & Generic 기업입니다. 현재가 $18.57 (+1.59%), 시가총액 $3.80B, PER (주가수익비율) 32.22, 52주 최저~최고 $7.16 ~ $15.19.
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, transdermal patches, and topicals. The Specialty segment develops, promotes, sells, and di
암닐 파마슈티컬스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
암닐 파마슈티컬스의 현재 주가는 $18.57 (+1.59%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
암닐 파마슈티컬스의 시가총액은 약 $3.80B입니다. PER은 32.22입니다.
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in